Our Pricing

Wegovy 1.7mg In Stock Now - £79.00 UK Price

Finding wegovy 1.7mg in stock uk can be challenging during ongoing supply constraints. At Cured Pharmacy, we maintain consistent stock of Wegovy 1.7mg pens at £79.00, with transparent pricing shown upfront and a free clinical consultation completed in under three minutes by UK-registered prescribers.

Understanding Wegovy 1.7mg Dosage in Your Weight Loss Journey

Wegovy 1.7mg represents the fourth escalation dose in the semaglutide titration schedule, typically reached during week 13 of treatment [1]. This dose serves as a crucial stepping stone before reaching the maintenance dose of 2.4mg, allowing your body to gradually adapt to higher semaglutide levels whilst minimising gastrointestinal side effects.

Clinical protocols require patients to remain on the 1.7mg dose for at least four weeks before advancing to the full maintenance dose [1]. This gradual escalation approach, validated in the STEP clinical trial programme, significantly reduces the incidence of nausea and vomiting compared to rapid dose increases [2]. Your UK prescriber will assess your tolerance and weight loss progress before approving advancement to the next dose level.

Why Wegovy 1.7mg Stock Availability Matters

The UK has experienced intermittent Wegovy supply constraints since its initial launch, with certain dose strengths facing greater shortages than others [3]. The 1.7mg dose has been particularly affected because patients spend a minimum of four weeks at this level, creating sustained demand that can outpace manufacturing capacity.

Interrupting your Wegovy treatment due to stock unavailability can compromise your weight loss results and require restarting the titration schedule from a lower dose [3]. At Cured Pharmacy, we prioritise supply chain management to maintain consistent stock levels across all Wegovy doses, ensuring treatment continuity for our patients.

What Happens If You Miss Doses

If more than two weeks elapse since your last Wegovy injection, MHRA guidance recommends restarting from the 0.25mg dose to minimise side effects [1]. This means losing weeks or months of progress through the titration schedule. Securing a pharmacy with reliable stock prevents these setbacks and maintains your momentum towards your weight loss goals.

How Wegovy 1.7mg Compares to Alternative Treatments

Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics the natural hormone glucagon-like peptide-1 to regulate appetite and food intake [2]. In the landmark STEP-1 trial, participants achieved an average 14.9% body weight reduction over 68 weeks on the full Wegovy dose, significantly outperforming placebo and lifestyle interventions alone [2].

Newer dual-action treatments have emerged in the UK market, offering alternative mechanisms for patients who may benefit from different therapeutic approaches. Your clinical assessment will consider your medical history, previous weight loss attempts, and individual health factors to determine the most suitable treatment option subject to prescriber approval.

Semaglutide vs Tirzepatide Mechanisms

Whilst semaglutide activates GLP-1 receptors exclusively, tirzepatide-based treatments activate both GLP-1 and GIP receptors, producing dual hormone effects [4]. Clinical trials suggest this dual mechanism may produce greater average weight loss in some patient populations, though individual responses vary considerably [4]. Both medications require once-weekly subcutaneous injection and gradual dose titration under medical supervision.

Starting Your Wegovy 1.7mg Treatment at Cured Pharmacy

All Wegovy prescriptions at Cured Pharmacy require completion of a clinical assessment by our UK-registered prescribers, led by Superintendent Pharmacist Tarun Kumar (GPhC 2233073). The online consultation takes under three minutes and evaluates your BMI, medical history, current medications, and contraindications to ensure Wegovy is clinically appropriate for you.

Wegovy 1.7mg is typically prescribed to patients already established on lower doses who have demonstrated good tolerance and are progressing through the standard titration schedule [1]. If you're new to semaglutide treatment, your prescriber will initiate therapy at the 0.25mg starting dose, with subsequent dose escalations occurring at four-week intervals subject to clinical review.

Wegovy 1.7mg Pricing and What's Included

At Cured Pharmacy, Wegovy 1.7mg is priced at £79.00 per pen, with transparent pricing displayed before you begin the consultation process. This represents competitive UK pricing compared to typical market rates, and includes your medication, clinical consultation, prescription processing, and discreet delivery to your UK address.

Each Wegovy pen contains four pre-measured doses of 1.7mg, providing a four-week supply when used as directed with once-weekly injections [1]. Your pen arrives with comprehensive patient information leaflets and injection technique guidance. Our pharmacy team remains available on (+44) 116 4646009 to answer questions about administration, storage, or side effect management throughout your treatment.

Understanding Long-Term Treatment Costs

Weight loss with Wegovy requires sustained treatment, with clinical trials demonstrating that discontinuation often leads to weight regain [2]. Most patients remain on the maintenance 2.4mg dose for 12-24 months or longer, depending on individual goals and clinical response. Your UK prescriber will conduct regular reviews to assess ongoing suitability and adjust treatment plans as needed.

Managing Side Effects at the Wegovy 1.7mg Dose

The most commonly reported side effects at the 1.7mg dose include nausea, diarrhoea, vomiting, constipation, and abdominal discomfort [1][2]. These gastrointestinal effects typically peak during the first few days after dose escalation and gradually diminish as your body adapts to the higher semaglutide level.

Clinical strategies to minimise side effects include eating smaller portions, avoiding high-fat meals, staying well-hydrated, and timing your injection consistently each week [2]. If side effects become intolerable, your prescriber may recommend remaining at the 1.7mg dose for an additional four weeks before attempting further escalation, or in some cases, temporarily reducing to the previous dose level.

Serious but rare side effects requiring immediate medical attention include severe abdominal pain (potential pancreatitis), visual changes, persistent vomiting leading to dehydration, or signs of thyroid nodules [1]. Contact your GP or NHS 111 immediately if you experience any concerning symptoms whilst taking Wegovy.

Scientific References

1. Novo Nordisk. (2023). Wegovy 2.4 mg solution for injection in pre-filled pen: Summary of Product Characteristics. Electronic Medicines Compendium. Retrieved from https://www.medicines.org.uk/emc/product/13799
2. Wilding, J. P. H., et al. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine, 384(11), 989–1002. https://doi.org/10.1056/NEJMoa2032183
3. Medicines and Healthcare products Regulatory Agency. (2023). Supply update and guidance for GLP-1 receptor agonists used for the treatment of obesity. GOV.UK. Retrieved from https://www.gov.uk/drug-safety-update
4. Jastreboff, A. M., et al. (2022). Tirzepatide Once Weekly for the Treatment of Obesity. New England Journal of Medicine, 387(3), 205–216. https://doi.org/10.1056/NEJMoa2206038

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication.